188 related articles for article (PubMed ID: 8703689)
1. PET scanning said to save money and improve staging of lung cancer.
Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689
[No Abstract] [Full Text] [Related]
2. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
Giaccone G
J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929
[No Abstract] [Full Text] [Related]
3. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Makler PT
J Nucl Med; 1997 Jul; 38(7):1173-4. PubMed ID: 9225819
[No Abstract] [Full Text] [Related]
4. Metabolic staging of lung cancer.
Berlangieri SU; Scott AM
N Engl J Med; 2000 Jul; 343(4):290-2. PubMed ID: 10911013
[No Abstract] [Full Text] [Related]
5. Staging of non-small-cell lung cancer with positron-emission tomography.
Donckier JE; Roelants V; Pochet JM
N Engl J Med; 2000 Nov; 343(21):1572; author reply 1572-3. PubMed ID: 11184751
[No Abstract] [Full Text] [Related]
6. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
[TBL] [Abstract][Full Text] [Related]
7. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
[TBL] [Abstract][Full Text] [Related]
8. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
Ung YC; Maziak DE; Vanderveen JA; Smith CA; Gulenchyn K; Lacchetti C; Evans WK;
J Natl Cancer Inst; 2007 Dec; 99(23):1753-67. PubMed ID: 18042932
[TBL] [Abstract][Full Text] [Related]
9. Staging of non-small-cell lung cancer and application of FDG-PET. A cost modeling approach.
Verboom P; Herder GJ; Hoekstra OS; Smit EF; van den Bergh JH; van Velthoven PC; Grijseels EW
Int J Technol Assess Health Care; 2002; 18(3):576-85. PubMed ID: 12391950
[TBL] [Abstract][Full Text] [Related]
10. PET in lung cancer staging.
Coleman RE
Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
[TBL] [Abstract][Full Text] [Related]
11. [PET Scan in the work-up of NSCLC].
Fornito MC
Suppl Tumori; 2004; 3(2):S21-4. PubMed ID: 15067959
[No Abstract] [Full Text] [Related]
12. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
Bury T; Dowlati A; Paulus P; Hustinx R; Radermecker M; Rigo P
Eur J Nucl Med; 1996 Feb; 23(2):204-6. PubMed ID: 8925857
[TBL] [Abstract][Full Text] [Related]
13. Staging of non-small-cell lung cancer with positron-emission tomography.
Rosell R
N Engl J Med; 2000 Nov; 343(21):1572; author reply 1572-3. PubMed ID: 11184750
[No Abstract] [Full Text] [Related]
14. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Scott WJ; Gobar LS; Hauser LG; Sunderland JJ; Dewan NA; Sugimoto JT
Chest; 1995 Apr; 107(4):1174-6. PubMed ID: 7705136
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of early cancer with positron emission tomography].
Kubota K
Nihon Rinsho; 1996 May; 54(5):1263-7. PubMed ID: 8965348
[TBL] [Abstract][Full Text] [Related]
16. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Wahl RL; Quint LE; Greenough RL; Meyer CR; White RI; Orringer MB
Radiology; 1994 May; 191(2):371-7. PubMed ID: 8153308
[TBL] [Abstract][Full Text] [Related]
17. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
Groheux D; Quere G; Blanc E; Lemarignier C; Vercellino L; de Margerie-Mellon C; Merlet P; Querellou S
Diagn Interv Imaging; 2016 Oct; 97(10):1003-1017. PubMed ID: 27567555
[TBL] [Abstract][Full Text] [Related]
18. [Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan].
Kubota K; Yamada S; Fukuda H; Tanida T; Saitou Y; Takahashi J; Yamada K
Kaku Igaku; 1997 May; 34(5):329-36. PubMed ID: 9248260
[TBL] [Abstract][Full Text] [Related]
19. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
[TBL] [Abstract][Full Text] [Related]
20. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
Laking G; Price P
Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
